Yüklüyor......

Modified Toxicity Probability Interval Design: A Safer and More Reliable Method Than the 3 + 3 Design for Practical Phase I Trials

The 3 + 3 design is the most common choice among clinicians for phase I dose-escalation oncology trials. In recent reviews, more than 95% of phase I trials have been based on the 3 + 3 design. Given that it is intuitive and its implementation does not require a computer program, clinicians can condu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ji, Yuan, Wang, Sue-Jane
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2013
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3641699/
https://ncbi.nlm.nih.gov/pubmed/23569307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.45.7903
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!